Community/Retail

Sarilumab is a fully human monoclonal antibody indicated for patients with polymyalgia rheumatica who had an inadequate response to corticosteroids or are unable to tolerate corticosteroid taper.

Study results indicates that the injectable antiretroviral therapy can benefit patients who are historically underserved and may face treatment barriers, including those with mental illness.

The set of principles seeks to improve publication patterns to show the value of the pharmacist and how journals can strengthen pharmacy practice as a scientific discipline.

Because 1 thing is not enough.

The drug is indicated for moderate to severe plaque psoriasis.

Companies seek FDA approval for individuals aged 12 years and older to receive vaccinations for their primary series.

Many laws also allow physicians to decide which information they disclose to guardians or fail to address inadvertent breaches of confidentiality through insurance billing and claims.

Patients who had relapsed or treatment-resistant cancer at baseline, or those who had more severe acute COVID-19 infections, were less likely to develop long COVID-19.

Cases discuss patients with medication allergies and drug interactions.

AI models can predict pharmacy foot traffic and peak service times, and even analyze patient histories to single out who picks up their prescriptions on time.

Zavegepant is the first calcitonin gene-related peptide receptor for migraines in development as an intranasal formulation studied in a phase 3 trial.

Phase 3 trial results indicate efficacy against respiratory syncytial virus-lower respiratory tract disease in individuals aged 60 years and older.

The COVID-19 and flu test is a single-use at-home test kit that uses self-collected nasal swab samples and provides results in approximately 30 minutes.

Virologic suppression was similar between the long-acting and once-daily treatments for HIV, but participants were more satisfied with the former.

Lenacapavir, combined with broadly neutralizing HIV antibodies, found effective at viral suppression in patients with HIV.

Farah Towfic, PharmD, MBA, RPh, director, CEO Operations, US Pharmacopeia, discusses some of the primary topics impacting pharmacists’ delivery of care and quality this year.

Ideally, older patients receive vaccinations by October, but disease activity often peaks in February or March.

Results of the ACTIV-6 study showed that high dose ivermectin use did not demonstrate a clinical benefit for mild to moderate COVID-19.

Products range from Parkinson disease treatment to medication for epilepsy.

Cognitive performance was higher if a person maintained physical activity throughout their lifetime.

Increasing interventions for affordable housing and food security could contribute to reduced rates of heart disease in lower income communities.

If approved, the vaccine would be the first immunization for use in pregnant individuals to help protect against the complications of respiratory syncytial virus in infants from birth through 6 months.

Including the ThinPrep Pap Test improves access to the benefits of the human papillomavirus (HPV) assay, which is the only FDA-approved assay that tests for an extended set of HPV types individually.

In a subgroup analysis, patients with COVID-19 who received conventional oxygen support also benefitted, having 20 fewer deaths per 1000 patients when given remdesivir.

Products include medications for depressive disorder and migraines.

Autoimmune diseases are often chronic conditions that can evolve, so minimizing damage and progression is typically the mainstay of treatment.

Sparsentan decreased proteinuria by nearly 50% in patients with IgA nephropathy, which may slow kidney function decline.

Case studies highlight questions about shingles.